Skip to main content
. 2023 Feb 2;9:40. doi: 10.1038/s41420-023-01315-2

Fig. 6. Combined treatment of XL413 and chemo suppresses resistant SCLC tumor growth in vivo.

Fig. 6

A Images of H69-AR xenograft tumors after XL413 (20 mg/kg) and chemo-therapy (2.5 mg/kg DDP and 4 mg/kg VP16) alone or combined treatment. B Tumor volume curve of xenograft tumors. The arrow indicated the start of treatments. C Body weight curve of H69-AR xenograft mice. The arrow indicated the start of treatments. D Tumor weight scatter plot of H69-AR xenograft model. E Inhibition rate of XL413 and chemo-therapy alone or combined treatment calculated via PDX HDRA.